Trademark: 90513988
Status Date
Monday, June 26, 2023
Filing Date
Friday, February 5, 2021
Published for Opposition
Tuesday, March 29, 2022
Abandoned Date
Monday, June 26, 2023
5 Pharmaceutical preparations for gene therapy and gene editing; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy; biotechnological platform technology, namely, biological nanoparticles for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; drug delivery agents consisting of compounds comprised of proteins in the form of capsids and particles that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents, in the form of injectable solutions, intravenous fluids, intracerebral solutions, intrathecal solutions, intracisternal solutions, intraocular solutions, intranasal solutions, intratracheal solutions, intraarterial solutions, intramuscular solutions, and medicinal infusions in that facilitate the delivery of capsids and particles used for delivery of gene therapy
42 medical and scientific research in the fields of gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that feature adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy
Aug 3, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Aug 3, 2023
Teas Change Of Correspondence Received
Aug 3, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 3, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 3, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 3, 2023
Teas Change Of Owner Address Received
Jun 26, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 26, 2023
Abandonment - No Use Statement Filed
Nov 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 18, 2022
Sou Extension 1 Granted
Nov 18, 2022
Sou Extension 1 Filed
Nov 18, 2022
Teas Extension Received
May 24, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 29, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 29, 2022
Published For Opposition
Mar 9, 2022
Notification Of Notice Of Publication E-Mailed
Feb 20, 2022
Approved For Pub - Principal Register
Feb 20, 2022
Examiner's Amendment Entered
Feb 20, 2022
Notification Of Examiners Amendment E-Mailed
Feb 20, 2022
Examiners Amendment E-Mailed
Feb 20, 2022
Examiners Amendment -Written
Feb 20, 2022
Previous Allowance Count Withdrawn
Feb 19, 2022
Approved For Pub - Principal Register
Jan 20, 2022
Teas/Email Correspondence Entered
Jan 20, 2022
Correspondence Received In Law Office
Jan 20, 2022
Teas Response To Office Action Received
Aug 30, 2021
Notification Of Non-Final Action E-Mailed
Aug 30, 2021
Non-Final Action E-Mailed
Aug 30, 2021
Non-Final Action Written
Aug 29, 2021
Assigned To Examiner
May 11, 2021
New Application Office Supplied Data Entered
Feb 9, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
